Lucosky Brookman LLP takes Akers Biosciences, Inc. Public on NASDAQ
Initial Public Offering of Common Stock on the NASDAQ Capital Markets, Dual-Listing on the AIM London Stock Exchange, and Capital Raise of $15,000,000;
Lucosky Brookman will join Akers Biosciences to Ring the NASDAQ Closing Bell on July 9, 2014
$CGRA hmmmmm, the bond deal is London Based as well.